Urinary Tract Infections: Vaccination
The question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 June 2025 to Question 57594 on Urinary Tract Infections: Vaccination, whether the Joint Committee on Vaccination and Immunisation (a) is reviewing and (b) plans to review available vaccines for Urinary Tract Infection for use in the UK.
Answered by Ashley Dalton
The Joint Committee on Vaccination and Immunisation (JCVI) has identified vaccines to prevent recurrent urinary tract infections (UTI). These are currently in development.
During a sub-committee meeting of the JCVI held on 25 November 2024, the pipeline vaccine against recurrent UTIs, known as uromune-MV140, was presented by its manufacturer, Inmunotek. Therapeutic vaccines are considered by the National Institute for Health and Care Excellence (NICE). The committee awaits advice on whether the NICE will review this product. The minutes of the JCVI’s subcommittee meeting have been published on the JCVI website, at the following link:
https://app.box.com/s/wv2uxkv7v9bisuf8ml8mdb19iemnzmv8/file/1808036070368
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →